request a live demo

Pharma & Life Sciences

Your research, manufacturing, and clinical systems are connected.
Your internal trust isn't governed.

Pharmaceutical and life sciences organizations operate some of the most complex internal networks in any industry. Research environments, GMP manufacturing facilities, clinical trial systems, and enterprise IT all converge on a single network – with trust relationships between them that are rarely visible and never continuously validated. The result is an ungoverned internal surface that puts your most valuable assets at risk: your intellectual property, your manufacturing continuity, and your regulatory standing. Enigma AI changes that. Agentless. Non-disruptive. Built for environments where a security misstep can have consequences far beyond the IT department.
Start 30-Day Pilot

The risk hidden inside pharma networks

Pharma and life sciences organizations are among the most targeted in the world. Nation-state actors pursue drug formulations and clinical trial data. Ransomware groups target manufacturing environments where downtime means spoiled batches and missed supply commitments. Once inside through a phishing email, a compromised CRO connection, or an unpatched lab instrument, attackers move laterally through trust relationships that no one has mapped or validated. In our pilots, pharma organizations consistently discover:

  • Research systems communicating with manufacturing environments in ways no one authorized
  • Lab instruments and connected equipment with broad internal access across flat network segments
  • CRO and contract manufacturer connections that were scoped for a project and never closed
  • Clinical trial platforms with trust relationships to enterprise systems that bypass intended access controls
  • Manufacturing control systems sitting in poorly segmented environments alongside corporate IT

The average cost of a pharmaceutical data breach is among the highest of any industry. But for pharma, the greater risk is often operational – a ransomware attack that halts a GMP manufacturing line doesn’t just cost money. It can trigger batch failures, regulatory reporting obligations, and supply disruptions that take months to recover from.

(Aberdeen Group / Siemens operational studies)

Internal Trust Governance
for pharma networks

Enigma AI deploys passively using lightweight network sensors – no agents, no changes to lab or manufacturing system configurations, no impact on GMP operations or research workflows. It continuously maps and validates every system-to-system communication across your environment, giving security teams the visibility they’ve never had over internal trust across research, manufacturing, and clinical systems.

  • Discover every asset across IT, OT, lab, and manufacturing environments – including instruments and connected devices other tools miss
  • Map communication relationships and identify trust paths inconsistent with system intent
  • Generate segmentation policy based on how systems actually communicate – critical for environments where microsegmentation has stalled due to complexity
  • Monitor continuously for trust drift as CRO connections, vendor access, and system configurations change

Enigma AI works across pharmaceutical manufacturers, biotech companies, CROs, medical device manufacturers, and life sciences organizations navigating complex OT/IT/lab convergence.

Compliance & regulatory alignment

Pharma and life sciences organizations operate under some of the most demanding regulatory frameworks of any industry. Enigma AI supports audit readiness across the requirements that matter most:

FDA 21 CFR Part 11

electronic records and systems integrity requirements, increasingly interpreted to include network-level governance of systems that handle regulated data

FDA cybersecurity guidance for drug manufacturers

expanding requirements for network monitoring and internal communication visibility in GMP environments

DORA (Digital Operational Resilience Act)

EU requirements for operational resilience and ICT risk management affecting pharma organizations operating in European markets

NIST Cybersecurity Framework

widely adopted for internal network governance and risk management across life sciences

GxP compliance

network segmentation and internal communication governance increasingly expected in GMP, GLP, and GCP environments during regulatory inspections

Enigma AI helps organizations meet these expectations by providing continuous visibility into internal network communications and enabling segmentation strategies that hold up under regulatory scrutiny.

See your internal trust surface in 30 days

Most pharma security teams have never seen a complete map of system-to-system trust relationships across their research, manufacturing, and clinical environments. Our 30-day pilot delivers exactly that – a full Internal Risk Index across your IT, OT, and lab network, with no agents and no disruption to GMP operations or research workflows.

Request a Live Demo
Start 30-Day Pilot